Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
Phase 2
- Conditions
- ANCA Associated VasculitisGranulomatosis With Polyangiitis
- Interventions
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Rachel Jones
- Target Recruit Count
- 31
- Registration Number
- NCT03967925
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, United Kingdom
🇬🇧Glasgow Royal Infirmary, Glasgow, United Kingdom
🇬🇧Imperial College London, London, United Kingdom
News
No news found